0 XP   0   0   0

Oncorus Inc










Financial Health of Oncorus




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Oncorus Inc
Buy, Hold or Sell?

Should you buy, hold or sell Oncorus?

I guess you are interested in Oncorus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Oncorus

Let's start. I'm going to help you getting a better view of Oncorus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Oncorus Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Oncorus Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Oncorus Inc. The closing price on 2022-12-02 was $0.4594 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Oncorus Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Oncorus Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oncorus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncorus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Oncorus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • -11.9% Return on Assets means that Oncorus generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncorus Inc:

  • The MRQ is -11.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-10.4%-1.6%
TTM-10.4%YOY-6.9%-3.5%
TTM-10.4%5Y-13.3%+2.9%
5Y-13.3%10Y-13.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-9.9%-2.0%
TTM-10.4%-8.9%-1.5%
YOY-6.9%-9.3%+2.4%
5Y-13.3%-11.7%-1.6%
10Y-13.3%-12.7%-0.6%
1.1.3. Return on Equity

Shows how efficient Oncorus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • -24.5% Return on Equity means Oncorus generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncorus Inc:

  • The MRQ is -24.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-18.7%-5.8%
TTM-18.7%YOY-9.2%-9.5%
TTM-18.7%5Y-12.1%-6.7%
5Y-12.1%10Y-12.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.5%-12.0%-12.5%
TTM-18.7%-11.5%-7.2%
YOY-9.2%-10.8%+1.6%
5Y-12.1%-14.2%+2.1%
10Y-12.1%-15.2%+3.1%

1.2. Operating Efficiency of Oncorus Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oncorus is operating .

  • Measures how much profit Oncorus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncorus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Oncorus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncorus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of Oncorus Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oncorus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.97 means the company has $4.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncorus Inc:

  • The MRQ is 4.965. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.496. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.965TTM6.496-1.531
TTM6.496YOY18.835-12.339
TTM6.4965Y10.952-4.456
5Y10.95210Y10.9520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9655.117-0.152
TTM6.4965.755+0.741
YOY18.8355.854+12.981
5Y10.9526.511+4.441
10Y10.9526.222+4.730
1.3.2. Quick Ratio

Measures if Oncorus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • A Quick Ratio of 7.23 means the company can pay off $7.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncorus Inc:

  • The MRQ is 7.225. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.873. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.225TTM7.873-0.648
TTM7.873YOY18.492-10.619
TTM7.8735Y10.822-2.949
5Y10.82210Y10.8220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2254.284+2.941
TTM7.8734.664+3.209
YOY18.4924.787+13.705
5Y10.8225.218+5.604
10Y10.8225.182+5.640

1.4. Solvency of Oncorus Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oncorus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oncorus to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that Oncorus assets are financed with 51.3% credit (debt) and the remaining percentage (100% - 51.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oncorus Inc:

  • The MRQ is 0.513. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.413. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.513TTM0.413+0.100
TTM0.413YOY0.249+0.165
TTM0.4135Y0.891-0.477
5Y0.89110Y0.8910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5130.278+0.235
TTM0.4130.277+0.136
YOY0.2490.306-0.057
5Y0.8910.367+0.524
10Y0.8910.403+0.488
1.4.2. Debt to Equity Ratio

Measures if Oncorus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oncorus to the Biotechnology industry mean.
  • A Debt to Equity ratio of 105.5% means that company has $1.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncorus Inc:

  • The MRQ is 1.055. The company is able to pay all its debts with equity. +1
  • The TTM is 0.753. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.055TTM0.753+0.301
TTM0.753YOY0.332+0.421
TTM0.7535Y0.384+0.369
5Y0.38410Y0.3840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0550.315+0.740
TTM0.7530.317+0.436
YOY0.3320.319+0.013
5Y0.3840.403-0.019
10Y0.3840.462-0.078

2. Market Valuation of Oncorus Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Oncorus generates.

  • Above 15 is considered overpriced but always compare Oncorus to the Biotechnology industry mean.
  • A PE ratio of -1.13 means the investor is paying $-1.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncorus Inc:

  • The EOD is -0.608. Company is losing money. -2
  • The MRQ is -1.125. Company is losing money. -2
  • The TTM is -3.084. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.608MRQ-1.125+0.517
MRQ-1.125TTM-3.084+1.959
TTM-3.084YOY-34.331+31.246
TTM-3.0845Y-12.472+9.387
5Y-12.47210Y-12.4720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.608-8.986+8.378
MRQ-1.125-9.792+8.667
TTM-3.084-16.243+13.159
YOY-34.331-20.876-13.455
5Y-12.472-16.665+4.193
10Y-12.472-14.732+2.260
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Oncorus.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Oncorus Inc:

  • The MRQ is 41.734. Seems overpriced? -1
  • The TTM is 22.057. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ41.734TTM22.057+19.677
TTM22.057YOY166.231-144.174
TTM22.0575Y94.144-72.087
5Y94.14410Y94.1440.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ41.734-0.032+41.766
TTM22.0570.004+22.053
YOY166.2310.016+166.215
5Y94.1440.006+94.138
10Y94.1440.003+94.141

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oncorus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.28 means the investor is paying $0.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncorus Inc:

  • The EOD is 0.149. Very good. +2
  • The MRQ is 0.276. Very good. +2
  • The TTM is 0.483. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.149MRQ0.276-0.127
MRQ0.276TTM0.483-0.207
TTM0.483YOY3.033-2.550
TTM0.4835Y1.172-0.689
5Y1.17210Y1.1720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1491.835-1.686
MRQ0.2762.006-1.730
TTM0.4832.774-2.291
YOY3.0333.453-0.420
5Y1.1722.713-1.541
10Y1.1722.402-1.230
2. Total Gains per Share

2.4. Latest News of Oncorus Inc

Does Oncorus Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Oncorus Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-07
18:00
Oncorus, Inc. (ONCR) Moves to Buy: Rationale Behind the UpgradeRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncorus Inc.

3.1. Institutions holding Oncorus Inc

Institutions are holding 66.6% of the shares of Oncorus Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Deerfield Management Co12.1240.0818314897700
2022-06-30Mpm Asset Management, LLC10.97081.5149284946400
2022-06-30MPM Oncology Impact Management LP9.15190.832237703100
2022-06-30CHI Advisors LLC9.11491.13932367436-50000-2.0683
2022-06-30Citadel Advisors Llc7.28290.0006189159231230.1654
2022-06-30Fosun International Ltd3.70510.168196232300
2022-06-30Vanguard Group Inc2.12770552640-33970-5.7909
2022-06-30Sphera Funds Management Ltd.2.08010.072954025800
2022-06-30Millennium Management LLC1.45430.00033777323777320
2022-06-30Renaissance Technologies Corp0.83720.00032174504191823.8805
2022-06-30Two Sigma Advisers, LLC0.58020.0005150700-18500-10.9338
2022-06-30Geode Capital Management, LLC0.53220138226-157983-53.335
2022-06-30Goldman Sachs Group Inc0.45401179253066835.1468
2022-06-30We Are One Seven, LLC0.44810.020311638900
2022-06-30Two Sigma Investments LLC0.38880.0004100992-52634-34.2611
2022-06-30Ergoteles LLC0.37960.003798600986000
2022-06-30Bridgeway Capital Management, LLC0.32070.002483300-35000-29.5858
2022-06-30State Street Corporation0.27070135-248947-78.0198
2022-06-30Bank of New York Mellon Corp0.2581067025-55022-45.0826
2022-06-30Letko, Brosseau & Associates Inc0.22770.00135915000
Total 62.70833.838816287345-100015-0.6%

3.2. Funds holding Oncorus Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Vanguard Total Stock Mkt Idx Inv1.0197026484200
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr1.01970264842-56290-17.5286
2022-10-31Vanguard Extended Market Index Investor0.86610.000222496100
2022-10-31iShares Biotechnology ETF0.460.00111194765700.4794
2022-06-30Bridgeway Ultra-Small Company Market0.32070.055283300-35000-29.5858
2022-09-30Fidelity® Extended Market Index0.27850.00027234000
2022-03-31iShares Russell 2000 Small-Cap Idx Instl0.11560.00133001300
2022-09-30Spartan Total Market Index Pool E0.09150.00012376000
2022-09-30Fidelity® Series Total Market Index0.073401907600
2022-09-30Fidelity® Total Market Index0.061501597400
2022-09-30NT Ext Equity Mkt Idx Fd - L0.05130.00031331300
2022-09-30Northern Trust Extended Eq Market Idx0.05130.00031331300
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.05080.00021320300
2022-10-31iShares Nasdaq US Biotech ETF USD Acc0.04270.00181108500
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0410.0002106461421.3519
2022-09-30State St US Extended Mkt Indx NL Cl C0.02230.0002580000
2022-09-30SSgA U.S. Extended Market Index Class I0.02230.0002580000
2022-09-30Fidelity® NASDAQ Composite Index®0.01930501300
2022-09-30Vanguard U.S. Eq Idx £ Acc0.0190492600
2022-02-28The Vanguard Total Stock Market Index0.01360.0001353500
Total 4.64030.06141205218-90578-7.5%

3.3. Insider Transactions

Insiders are holding 8.927% of the shares of Oncorus Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000
2022-05-25Rick WanstallBUY37771.251000

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Oncorus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.693-0.653-6%2.561-127%0.257-370%0.257-370%
Book Value Growth---0.225-0.172-24%0.483-147%0.330-168%0.330-168%
Book Value Per Share--3.0804.249-28%5.981-49%2.645+16%2.645+16%
Book Value Per Share Growth---0.225-0.172-24%0.483-147%0.330-168%0.330-168%
Current Ratio--4.9656.496-24%18.835-74%10.952-55%10.952-55%
Debt To Asset Ratio--0.5130.413+24%0.249+106%0.891-42%0.891-42%
Debt To Equity Ratio--1.0550.753+40%0.332+218%0.384+175%0.384+175%
Dividend Per Share----0%0.164-100%0.055-100%0.055-100%
Eps---0.755-0.735-3%-0.546-28%-0.602-20%-0.602-20%
Eps Growth---0.027-0.034+27%0.143-119%0.054-149%0.054-149%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.149-85%0.2760.483-43%3.033-91%1.172-76%1.172-76%
Pe Ratio-0.608+46%-1.125-3.084+174%-34.331+2951%-12.472+1008%-12.472+1008%
Peg Ratio--41.73422.057+89%166.231-75%94.144-56%94.144-56%
Price Per Share0.459-85%0.8502.290-63%17.348-95%6.546-87%6.546-87%
Price To Total Gains Ratio-0.662+46%-1.22624.646-105%-8.072+559%8.287-115%8.287-115%
Profit Growth---2.696-3.415+27%8.643-131%-3.119+16%-3.119+16%
Quick Ratio--7.2257.873-8%18.492-61%10.822-33%10.822-33%
Return On Assets---0.119-0.104-13%-0.069-43%-0.133+11%-0.133+11%
Return On Equity---0.245-0.187-24%-0.092-63%-0.121-51%-0.121-51%
Total Gains Per Share---0.693-0.653-6%2.725-125%0.311-323%0.311-323%
Total Gains Per Share Growth---0.0983.039-103%-1.854+1795%0.404-124%0.404-124%
Usd Book Value--79996000.000110357750.000-28%155348250.000-49%68686000.000+16%68686000.000+16%
Usd Book Value Change Per Share---0.693-0.653-6%2.561-127%0.257-370%0.257-370%
Usd Book Value Per Share--3.0804.249-28%5.981-49%2.645+16%2.645+16%
Usd Dividend Per Share----0%0.164-100%0.055-100%0.055-100%
Usd Eps---0.755-0.735-3%-0.546-28%-0.602-20%-0.602-20%
Usd Price Per Share0.459-85%0.8502.290-63%17.348-95%6.546-87%6.546-87%
Usd Profit---19620000.000-19083500.000-3%-14121500.000-28%-14868250.000-24%-14868250.000-24%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.693-0.653-6%2.725-125%0.311-323%0.311-323%
 EOD+3 -2MRQTTM+4 -23YOY+5 -245Y+9 -2010Y+9 -20

4.2. Fundamental Score

Let's check the fundamental score of Oncorus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.608
Price to Book Ratio (EOD)Between0-10.149
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.225
Current Ratio (MRQ)Greater than14.965
Debt to Asset Ratio (MRQ)Less than10.513
Debt to Equity Ratio (MRQ)Less than11.055
Return on Equity (MRQ)Greater than0.15-0.245
Return on Assets (MRQ)Greater than0.05-0.119
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Oncorus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.467
Ma 20Greater thanMa 500.567
Ma 50Greater thanMa 1000.693
Ma 100Greater thanMa 2001.010
OpenGreater thanClose0.500
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-09-302021-12-312022-03-312022-06-302022-09-30
Net Debt  -102,1421,390-100,75276,842-23,9109,760-14,15021,8677,717



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets164,365
Total Liabilities84,369
Total Stockholder Equity79,996
 As reported
Total Liabilities 84,369
Total Stockholder Equity+ 79,996
Total Assets = 164,365

Assets

Total Assets164,365
Total Current Assets83,479
Long-term Assets83,479
Total Current Assets
Cash And Cash Equivalents 41,568
Short-term Investments 39,955
Other Current Assets 1,956
Total Current Assets  (as reported)83,479
Total Current Assets  (calculated)83,479
+/-0
Long-term Assets
Property Plant Equipment 76,880
Long-term Assets Other 4,006
Long-term Assets  (as reported)80,886
Long-term Assets  (calculated)80,886
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,813
Long-term Liabilities67,556
Total Stockholder Equity79,996
Total Current Liabilities
Short-term Debt 1,138
Accounts payable 1,980
Other Current Liabilities 13,695
Total Current Liabilities  (as reported)16,813
Total Current Liabilities  (calculated)16,813
+/-0
Long-term Liabilities
Long term Debt 19,257
Capital Lease Obligations Min Short Term Debt48,147
Long-term Liabilities Other 152
Long-term Liabilities  (as reported)67,556
Long-term Liabilities  (calculated)67,556
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -251,078
Accumulated Other Comprehensive Income -73
Other Stockholders Equity 331,144
Total Stockholder Equity (as reported)79,996
Total Stockholder Equity (calculated)79,996
+/-0
Other
Capital Stock3
Cash and Short Term Investments 81,523
Common Stock Shares Outstanding 25,972
Liabilities and Stockholders Equity 164,365
Net Debt 7,717
Net Invested Capital 99,253
Net Tangible Assets 98,008
Net Working Capital 66,666
Short Long Term Debt Total 49,285



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
50,826
0
35,815
62,059
182,263
225,107
215,610
202,727
220,734
176,568
182,540
164,365
164,365182,540176,568220,734202,727215,610225,107182,26362,05935,815050,8260
   > Total Current Assets 
45,901
45,901
30,592
30,592
55,596
133,391
175,532
162,689
147,711
129,110
102,608
102,764
83,479
83,479102,764102,608129,110147,711162,689175,532133,39155,59630,59230,59245,90145,901
       Cash And Cash Equivalents 
0
45,286
0
28,921
54,019
130,305
172,622
159,920
145,603
100,752
75,509
84,797
41,568
41,56884,79775,509100,752145,603159,920172,622130,30554,01928,921045,2860
       Short-term Investments 
0
0
0
0
0
0
0
0
0
23,173
23,156
15,442
39,955
39,95515,44223,15623,173000000000
       Other Current Assets 
0
615
0
1,671
1,577
3,086
2,910
2,769
2,108
5,185
3,943
2,525
1,956
1,9562,5253,9435,1852,1082,7692,9103,0861,5771,67106150
   > Long-term Assets 
0
4,925
0
5,223
6,463
48,872
49,575
52,921
55,016
91,624
73,960
79,776
80,886
80,88679,77673,96091,62455,01652,92149,57548,8726,4635,22304,9250
       Property Plant Equipment 
4,475
4,475
4,773
4,773
4,506
45,545
46,248
49,430
51,521
68,451
69,674
75,387
76,880
76,88075,38769,67468,45151,52149,43046,24845,5454,5064,7734,7734,4754,475
       Long Term Investments 
0
0
0
0
0
0
0
0
0
23,173
0
0
0
00023,173000000000
       Long-term Assets Other 
0
450
0
450
1,957
3,327
3,327
3,491
3,495
4,026
4,286
4,389
4,006
4,0064,3894,2864,0263,4953,4913,3273,3271,95745004500
> Total Liabilities 
0
125,123
0
7,556
180,316
47,599
48,852
52,978
54,885
71,565
62,310
84,532
84,369
84,36984,53262,31071,56554,88552,97848,85247,599180,3167,5560125,1230
   > Total Current Liabilities 
4,938
4,938
6,133
6,133
5,133
5,984
6,769
10,744
12,335
20,974
12,145
16,016
16,813
16,81316,01612,14520,97412,33510,7446,7695,9845,1336,1336,1334,9384,938
       Short-term Debt 
0
0
0
0
0
993
1,037
1,084
1,132
1,684
1,678
2,300
1,138
1,1382,3001,6781,6841,1321,0841,03799300000
       Accounts payable 
942
942
1,895
1,895
1,470
1,245
2,524
1,959
1,425
13,009
3,582
7,157
1,980
1,9807,1573,58213,0091,4251,9592,5241,2451,4701,8951,895942942
       Other Current Liabilities 
475
3,996
497
4,238
3,663
3,746
3,208
7,701
9,778
6,281
6,885
6,559
13,695
13,6956,5596,8856,2819,7787,7013,2083,7463,6634,2384973,996475
   > Long-term Liabilities 
0
120,185
0
1,423
175,183
41,615
42,083
42,234
42,550
50,591
50,165
68,516
67,556
67,55668,51650,16550,59142,55042,23442,08341,615175,1831,4230120,1850
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
41,615
42,083
42,234
42,329
50,388
49,921
49,269
48,147
48,14749,26949,92150,38842,32942,23442,08341,61500000
       Long-term Liabilities Other 
0
1,876
0
2,501
0
41,615
42,083
42,234
42,550
0
244
169
152
152169244042,55042,23442,08341,61502,50101,8760
       Deferred Long Term Liability 
0
0
0
0
1,507
0
0
0
0
0
0
0
0
000000001,5070000
> Total Stockholder Equity
0
-74,297
0
28,259
-118,257
134,664
176,255
162,632
147,842
130,022
114,258
98,008
79,996
79,99698,008114,258130,022147,842162,632176,255134,664-118,25728,2590-74,2970
   Common Stock
0
0
1
1
0
2
3
3
3
3
3
3
3
3333333201100
   Retained Earnings Total Equity0000-174,744-158,016-142,488-129,82500000
   Accumulated Other Comprehensive Income -73-41-40-140000000-2,8510
   Capital Surplus 
0
0
0
0
0
264,487
318,740
320,645
322,583
0
0
0
0
0000322,583320,645318,740264,48700000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
2,851
0
124,582
0
264,487
318,740
320,645
322,583
324,620
326,662
329,504
331,144
331,144329,504326,662324,620322,583320,645318,740264,4870124,58202,8510



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-64,818
Operating Income-64,818-64,818
 
Operating Expense (+$)
Research Development44,682
Selling General Administrative20,136
Selling And Marketing Expenses-
Operating Expense64,81864,818
 
Net Interest Income (+$)
Interest Income65
Interest Expense-0
Net Interest Income6565
 
Pretax Income (+$)
Operating Income-64,818
Net Interest Income65
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-64,762-64,874
EBIT - interestExpense = -66,766
-64,762
-64,762
Interest Expense0
Earnings Before Interest and Taxes (ebit)-66,766-64,762
Earnings Before Interest and Taxes (ebitda)-64,818
 
After tax Income (+$)
Income Before Tax-64,762
Tax Provision--
Net Income From Continuing Ops-64,762-64,762
Net Income-64,762
Net Income Applicable To Common Shares-64,762
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net56-65
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
9 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
9 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
9 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
10 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
10 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
10 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
10 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
10 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
10 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
10 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
10 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
10 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
10 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
10 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
10 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
10 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
10 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
10 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
10 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart